Risk Assessment of Long-Haul Truck Drivers

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2010 by Wake Forest School of Medicine.
Recruitment status was  Recruiting
University of Alabama at Birmingham
Information provided by:
Wake Forest School of Medicine
ClinicalTrials.gov Identifier:
First received: September 26, 2006
Last updated: January 14, 2010
Last verified: January 2010

September 26, 2006
January 14, 2010
September 2005
August 2010   (final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT00381992 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
Risk Assessment of Long-Haul Truck Drivers
Risk Assessment of Long-Haul Truck Drivers

International studies have repeatedly documented a substantial prevalence of sexual risk behaviors and high rates of human immunodeficiency virus (HIV) and other sexually transmitted infections (STI) ranging from 5%-56% amongst long-distance truck drivers ("truckers") living in diverse international settings including India, Bangladesh, South Africa, China, Laos and Thailand. The prevalence of sexual risk factors and STI/HIV in US drivers is unknown. This proposal will provide both qualitative and quantitative data on HIV risk behaviors by interviewing and testing truckers working for established long-distance trucking firms, the sector which accounts for most of the jobs in the trucking and warehousing industry in the United States. The data obtained from this study will be used to inform the development of an HIV prevention intervention for long-haul truck drivers.

The study proposed in this R34 application will address the following specific aims:

Specific Aim 1. To perform focus groups and in-depth interviews with long-haul truck drivers to guide development of both a behavioral risk assessment instrument and an acceptable HIV/STI screening protocol for long-haul truckers.

Specific Aim 2. To perform in-depth interviews with trucking industry executives to determine barriers to routine HIV/STI assessment and screening of their employees.

Specific Aim 3. To perform a pilot phase with a subsample of long-haul truck drivers characterized by the following steps: TTM-based "cognitive interviews" (N=5); pilot testing of the survey and biomedical screening protocol (N=15); and a follow-up focus group (N=8)

Specific Aim 4. To assess a sample of (N=300) truck drivers for general health and sexual risk behaviors using the adapted theory-based survey and to determine the prevalence of hepatitis B, hepatitis C, hypertension, hyperlipidemia, diabetes and obesity, HIV, N. gonorrhoeae, and C. trachomatis

Time Perspective: Cross-Sectional
Not Provided
Not Provided
Non-Probability Sample

American long-haul truck drivers affiliated with participating companies or presenting as clients at participating truck stops.

  • Gonorrhea
  • Chlamydia Infections
  • Hepatitis B
  • Hepatitis C
  • Diabetes Mellitus
  • Hypertension
  • Obesity
  • HIV Infections
  • Hyperlipidemia
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
August 2010
August 2010   (final data collection date for primary outcome measure)

Inclusion Criteria:

  1. Long-haul truck driver as defined as a driver, part-time or full-time, who drives a truck across state lines (interstate)
  2. English speaking
  3. Age 21 or greater
  4. Willing to participate
  5. Able to provide written informed consent

Exclusion Criteria:

  1. Does not fit definition of truck driver in inclusion criteria #1
  2. Unwilling to participate
  3. Unwilling or unable to provide informed consent
  4. Unable to understand or speak English
  5. Age < 21 years
21 Years and older
Contact: Laura H Bachmann, MD, MPH 336-716-3100 lbachman@wfubmc.edu
United States
F060815005, 5R34MH073411-03
Laura Hinkle Bachmann, MD, MPH, Wake Forest University Health Sciences
Wake Forest School of Medicine
  • National Institute of Mental Health (NIMH)
  • University of Alabama at Birmingham
Principal Investigator: Laura H Bachmann, MD, MPH Wake Forest School of Medicine
Wake Forest School of Medicine
January 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP